Home
Archives
Contact

✕

Blog

Home
Blog

✕

FIND US

CATEGORIES

Editorials
New Trials
Ongoing Trials
Trial Results

LATEST POSTS

0
How blood tests are changing cancer research and patient care: Understanding liquid biopsies and circulating tumor DNA
August 17, 2026
0
Now Enrolling: The EA1242/RxFINE-Low research study is testing how to best prevent ER-positive, HER2-negative breast cancer from returning
August 17, 2026

RECENT COMMENTS

May 28, 2026
ECOG-ACRIN Staff commented on Ongoing Trial: For patients with advanced or rare cancers, NCI-MATCH may offer a treatment option
May 15, 2026
Bobbi Caron commented on Ongoing Trial: For patients with advanced or rare cancers, NCI-MATCH may offer a treatment option

TAGS

Advocacy Anal cancer Artificial intelligence (AI) Bladder cancer Brain cancer Breast cancer Colorectal cancer ComboMATCH Esophagus cancer Gallbladder cancer Head and neck cancer Health equity Immunotherapy In memory Kidney cancer Leukemia Liver cancer Lung cancer Lymphoma Mammography Melanoma Myelodysplastic syndrome Myeloma NCI-MATCH Older adults Pancreatic cancer Pancreatic cysts Patient-reported outcomes Patient education Patient navigation Penis cancer Personalized treatment Policy Precision medicine Prevention Prostate cancer Real-world data/evidence Research results Sarcoma Screening for cancer Side effects Survivorship Targeted therapy Upper tract urothelial cancer Young adults

Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2026 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc